Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BAS
Basis Energy Services, Inc.
BAS
|
+$159M |
| 2 |
Freeport-McMoran
FCX
|
+$137M |
| 3 |
Walt Disney
DIS
|
+$129M |
| 4 |
Alcoa
AA
|
+$98.7M |
| 5 |
CMA
Comerica
CMA
|
+$87.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$187M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$177M |
| 3 |
ANDV
Andeavor
ANDV
|
+$166M |
| 4 |
Canadian Pacific Kansas City
CP
|
+$160M |
| 5 |
Union Pacific
UNP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.65% |
| 2 | Consumer Discretionary | 12.25% |
| 3 | Healthcare | 12.08% |
| 4 | Energy | 7.79% |
| 5 | Materials | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
PUT
State Street SPDR S&P Metals & Mining ETF
XME
$4.77B
| $15.2M | 0.08% |
+500,000
| New | +$14.4M |
|
352
CVS Health
CVS
$119B
| $15.1M | 0.08% |
191,500
-8,349
| -4% | -$676K |
|
353
Baxter International
BAX
$13.6B
| $15.1M | 0.08% |
+340,023
| New | +$15.7M |
|
354
Mattel
MAT
$4.15B
| $15.1M | 0.08% |
547,140
-1,378,221
| -72% | -$41.9M |
|
355
Gaming and Leisure Properties
GLPI
$12.7B
| $15M | 0.08% |
489,819
+55,007
| +13% | +$1.72M |
|
356
ExxonMobil
XOM
$679B
| $14.9M | 0.08% |
+165,245
| New | +$14.4M |
|
357
Humana
HUM
$45.5B
| $14.8M | 0.08% |
72,398
-85,102
| -54% | -$16.2M |
|
358
American Airlines Group
AAL
$9.15B
| $14.7M | 0.08% |
315,712
-654,944
| -67% | -$28.5M |
|
359
Vulcan Materials
VMC
$35.8B
| $14.7M | 0.08% |
117,500
+37,500
| +47% | +$4.54M |
|
360
Devon Energy
DVN
$54B
| $14.7M | 0.08% |
321,618
-1,900,995
| -86% | -$83.9M |
|
361
PUT
C.H. Robinson
CHRW
$16.5B
| $14.7M | 0.08% |
+200,000
| New | +$14.5M |
|
362
Affiliated Managers Group
AMG
$9.21B
| $14.7M | 0.08% |
100,835
-11,028
| -10% | -$1.6M |
|
|
MRSH
363
Marsh
MRSH
$91.6B
| $14.6M | 0.08% |
215,636
+204,534
| +1,842% | +$13.7M |
|
364
Boston Properties
BXP
$10.8B
| $14.5M | 0.08% |
115,173
+79,371
| +222% | +$9.87M |
|
365
CALL
Kinder Morgan
KMI
$69B
| $14.3M | 0.08% |
+690,000
| New | +$14.6M |
|
366
Quest Diagnostics
DGX
$27B
| $14.2M | 0.08% |
+154,833
| New | +$13.3M |
|
367
Green Plains
GPRE
$1.14B
| $14.2M | 0.08% |
+508,827
| New | +$13.5M |
|
|
CAA
368
DELISTED
CalAtlantic Group, Inc.
CAA
| $14.2M | 0.08% |
+416,595
| New | +$13.8M |
|
|
369
PUT
Mattel
MAT
$4.15B
| $14.2M | 0.08% |
+514,000
| New | +$15.6M |
|
|
INXN
370
DELISTED
Interxion Holding N.V.
INXN
| $14.1M | 0.08% |
402,234
+253,138
| +170% | +$9.01M |
|
371
Golar LNG
GLNG
$5.31B
| $14.1M | 0.08% |
612,880
-357,611
| -37% | -$8.32M |
|
|
HBI
372
CALL
DELISTED
Hanesbrands
HBI
| $14M | 0.08% |
649,800
+470,556
| +263% | +$11.2M |
|
373
CALL
Alibaba
BABA
$286B
| $14M | 0.08% |
159,600
-9,423
| -6% | -$907K |
|
374
Valley National Bancorp
VLY
$7.82B
| $14M | 0.08% |
1,203,181
+778,298
| +183% | +$8.32M |
|
375
PUT
General Motors
GM
$77.2B
| $13.9M | 0.07% |
+400,000
| New | +$13.4M |
|
Similar funds
Dmitry Balyasny's Q4 2016 Portfolio in Review
As of Q4 2016, Dmitry Balyasny held 1,603 positions worth $18.6B, up 7.6% from $17.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Dmitry Balyasny's Q4 2016 filing shows 632 new, 338 increased, 353 reduced and 276 closed positions. Its largest new stake was Basis Energy Services, Inc.: 586,398 shares worth $20.7M. The largest sale was Eli Lilly, an estimated $187M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 9.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Dmitry Balyasny's largest Q4 2016 buy was Basis Energy Services, Inc.: 586,398 shares worth $20.7M.
- Dmitry Balyasny added most to Alcoa in Q4 2016, an estimated $98.7M increase.
- Dmitry Balyasny's biggest Q4 2016 reduction was Eli Lilly, cutting an estimated $187M.
- Dmitry Balyasny fully exited Canadian Pacific Kansas City in Q4 2016, selling an estimated $160M.
- Dmitry Balyasny's ten largest holdings make up 8.7% of its $18.6B portfolio in Q4 2016.
- Dmitry Balyasny opened 632 new positions and closed 276 in Q4 2016.
- Dmitry Balyasny's portfolio value rose 7.6% quarter-over-quarter to $18.6B.
Based on Balyasny Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.